Tag: Pazdur

ASCO News: BioNTech and Pfizer’s bispecifics, and Pazdur — Day 2

Adam Feuerstein/STAT Adam Feuerstein is a senior writer and biotech columnist, reporting on drug development, business, Wall Street,

After ‘destruction’ at FDA, Rick Pazdur sees need to ‘think creatively’

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected

Top drug regulator Richard Pazdur set to leave the FDA

Top drug regulator Richard Pazdur has announced his retirement from the Food and Drug Administration (FDA), adding to